Status:
COMPLETED
Computer-Based Tailored or Standard Information for Colorectal Cancer Screening
Lead Sponsor:
University of Michigan Rogel Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-79 years
Brief Summary
RATIONALE: A computer program that provides information on colorectal cancer screening based on a patient's test preferences may be more effective than a computer program that gives standard informati...
Detailed Description
OBJECTIVES: * To evaluate the effectiveness of a preference-tailored (PT) intervention vs standard information (SI) delivered via computer for increasing patients' adherence to colorectal cancer (CRC...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- At average risk for colorectal cancer (CRC), defined as the following:
- No personal history of CRC, adenomatous colon polyps, or inflammatory bowel disease
- No family history of CRC
- Not up-to-date with CRC screening in past year OR have never been screened, defined as
- Up-to-date screening is defined as having completed 1 of the following:
- Fecal occult blood test within the past 2 years
- Sigmoidoscopy within the past 5 years
- Colonoscopy with the past 10 years
- Double-contrast barium enema within the past 5 years
- Patient at San Francisco Community Health Network or at Henry Ford Health System and a member of the Health Alliance Plan
- PATIENT CHARACTERISTICS:
- Life expectancy ≥ 1 year
- No history of inflammatory bowel disease, polyposis, or hereditary nonpolyposis
- No severe comorbidity or significantly lowered life expectancy, including any of the following:
- Do not resuscitate (DNR)/do not intubate (DNI) code status
- Metastatic cancer
- End-stage congestive heart failure
- Severe chronic obstructive pulmonary disease
- Coronary artery disease with recent myocardial infarction or unstable angina
- Dementia
- PRIOR CONCURRENT THERAPY:
- No prior bowel resection
Exclusion
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
345 Patients enrolled
Trial Details
Trial ID
NCT00955188
Start Date
August 1 2004
End Date
May 1 2008
Last Update
December 21 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States, 94115
2
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States, 48109-0942
3
Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan, United States, 48202